title: IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays.
abstract: In 2011, the IFCC Task Force on Clinical Applications of Cardiac Bio-Markers (TF-CB) was formed, with the purpose of providing evidence based educational materials to assist all biomarker users, i.e. laboratorians, clinicians, researchers, in-vitro diagnostics and regulatory agencies, in better understanding important analytical and clinical aspects of established and novel cardiac biomarkers for use in clinical practice and research. The goal of the task force was to promulgate the same information conjointly through the in vitro diagnostic industry to the laboratory, emergency department and cardiologists. The initial undertaking of the TF-CB, which is comprised of laboratory medicine scientists, emergency medicine physicians and cardiologists, was to address two key issues pertaining to implementing high-sensitivity cardiac troponin (hs-cTn) assays in clinical practice: the 99th percentile upper reference limit (URL) and calculating serial change values in accord with the Universal Definition of AMI. The highlights of both concepts from IFCC statements are described.
authors.affiliation: Department of Laboratory Medicine and Pathology, Hennepin County Medical Center and University of Minnesota, Minneapolis, MN, USA. Electronic address: apple004@umn.edu.
authors.forename: Fred S
authors.initials: FS
authors.lastname: Apple
authors.affiliation: Cardiovascular Division, Mayo Clinic, Rochester,MN, USA.
authors.forename: Allan S
authors.initials: AS
authors.lastname: Jaffe
authors.affiliation: Department of Cardiology, St George's Hospital, London, UK; Department of Clinical Blood Sciences, St George's Hospital, London, UK.
authors.forename: Paul
authors.initials: P
authors.lastname: Collinson
authors.affiliation: Department of Cardiology, Charité-University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Mockel
authors.affiliation: Biochemistry Department, IIB-Sant Pau & Universitat Autònoma, Barcelona, Spain.
authors.forename: Jordi
authors.initials: J
authors.lastname: Ordonez-Llanos
authors.affiliation: Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, University of Uppsala, Sweden.
authors.forename: Bertil
authors.initials: B
authors.lastname: Lindahl
authors.affiliation: Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: Judd
authors.initials: J
authors.lastname: Hollander
authors.affiliation: Department of Laboratory Medicine, University-Hospital, Padova, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Plebani
authors.affiliation: Christchurch Hospital, Emergency Department, Christchurch, New Zealand.
authors.forename: Martin
authors.initials: M
authors.lastname: Than
authors.affiliation: Department of Chemical Pathology, Prince of Wales Hospital, Hong Kong, China.
authors.forename: M H M
authors.initials: MH
authors.lastname: Chan
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood; D002624:Chemistry, Clinical / Q000193:education*; D006801:Humans; D038622:Internationality; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis; D012016:Reference Values; D012958:Societies, Scientific; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood*
chemical_list: D015415:Biomarkers; D019210:Troponin I; D020107:Troponin T
keywords: 99th percentile; High-sensitivity cardiac troponin assays; IFCC; Myocardial infarction; Risk stratification